Antitumor effects of rhodium (II) complexes on mice bearing Ehrlich tumors.

Reibscheid, E M; Zyngier, S; Maria, D A; Mistrone, R J; Sinisterra, R D; Couto, L G; Najjar, R

Reibscheid, E M; Zyngier, S; Maria, D A; Mistrone, R J; Sinisterra, R D; Couto, L G; Najjar, R.

Affiliation

Reibscheid EM; Departamento de Farmacologia, Universidade de São Paulo, Brasil.

Braz J Med Biol Res ; 27(1): 91-4, 1994 Jan.

Article in En | MEDLINE | ID: mdl-8173534

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/pharmacology; Carcinoma, Ehrlich Tumor/drug therapy; Rhodium/pharmacology; Acetates/administration & dosage; Animals; Carcinoma, Ehrlich Tumor/mortality; Drug Screening Assays, Antitumor; Mice; Mice, Inbred BALB C; Sulfadiazine/administration & dosage; Sulfisoxazole/administration & dosage; Survival Rate; Time Factors; Trifluoroacetic Acid/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Rhodium / Carcinoma, Ehrlich Tumor / Antineoplastic Combined Chemotherapy Protocols Limits: Animals Language: En Journal: Braz J Med Biol Res Year: 1994 Type: Article Affiliation country: Brazil

Search on Google

XML

PubMed Links